InsidersTradesSigma
Follow the 인벤테라 stock price and the full directors' dealings record of the company, a listed equity based in South Korea. Shares trade on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, 인벤테라 has logged 8 public disclosures. Market capitalisation: €60.6bn. The latest transaction was filed on 9 April 2026 (Purchase). Among the most active insiders: 신태현. All data is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
8 of 8 declarations
Inventaera是一家在XKRX上市的医疗保健和制药公司。它专注于开发创新解决方案以提升医疗保健水平。